Basit öğe kaydını göster

dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorNazik, Hasan
dc.contributor.authorErmis, Fatih
dc.contributor.authorKurt, Ramazan
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorUyanikoglu, Ahmet
dc.contributor.authorPinarbasi, Binnur
dc.contributor.authorMungan, Zeynel
dc.date.accessioned2021-03-05T16:36:28Z
dc.date.available2021-03-05T16:36:28Z
dc.date.issued2011
dc.identifier.citationErmis F., Akyuz F., Uyanikoglu A., Kurt R., Pinarbasi B., Nazik H., Kaymakoglu S., Mungan Z., "Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer", SOUTHERN MEDICAL JOURNAL, cilt.104, ss.579-583, 2011
dc.identifier.issn0038-4348
dc.identifier.otherav_c17981da-1916-4f4b-9270-d9200ee7e9f8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/128400
dc.identifier.urihttps://doi.org/10.1097/smj.0b013e3182249be0
dc.description.abstractObjectives: First-line standard eradication efficacy with lansoprazole, amoxicillin and clarithromycin regressed over 10 years. The aim of this study was to evaluate the efficacy and tolerability of a levofloxacin-based regimen in patients with peptic ulcer after failure of the standard first-line H. pylori eradication therapy in a country with a high rate of infection.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectTemel Tıp Bilimleri
dc.titleSecond-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
dc.typeMakale
dc.relation.journalSOUTHERN MEDICAL JOURNAL
dc.contributor.department, ,
dc.identifier.volume104
dc.identifier.issue8
dc.identifier.startpage579
dc.identifier.endpage583
dc.contributor.firstauthorID201294


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster